Table 3 Markov modelling to assess transition probabilities of VMB dynamics among non-regressors and regressors at 0–12, 0–24 and 12–24 months.

From: The vaginal microbiota associates with the regression of untreated cervical intraepithelial neoplasia 2 lesions

From/ to

Regression

Non-Regression

0–12 months

      
 

CST I

CST III

CST IV

CST I

CST III

CST IV

 CST I

0.64

0.14

0.22

0.75

0.20

0.05

 CST III

0.09

0.59

0.32

0.18

0.67

0.15

 CST IV

0

0.17

0.83

0.03

0.28

0.69

0–24 months

 

CST I

CST III

CST IV

CST I

CST III

CST IV

 CST I

0.69

0.19

0.12

0.75

0.08

0.17

 CST III

0.12

0.63

0.25

0.23

0.58

0.19

 CST IV

0

0.20

0.80

0.05

0.38

0.57

12–24 months

 

CST I

CST III

CST IV

CST I

CST III

CST IV

 CST I

0.66

0.17

0.17

0.75

0

0.25

 CST III

0.08

0.67

0.25

0.38

0.38

0.24

 CST IV

0.14

0.29

0.57

0

0.14

0.86

  1. CST Community state type
Back to article page